152 related articles for article (PubMed ID: 28652462)
1. Protective Low-Frequency Variants for Preeclampsia in the Fms Related Tyrosine Kinase 1 Gene in the Finnish Population.
Lokki AI; Daly E; Triebwasser M; Kurki MI; Roberson EDO; Häppölä P; Auro K; Perola M; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Salmon JE; Meri S; Daly M; Atkinson JP; Laivuori H
Hypertension; 2017 Aug; 70(2):365-371. PubMed ID: 28652462
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis.
Gray KJ; Saxena R; Karumanchi SA
Am J Obstet Gynecol; 2018 Feb; 218(2):211-218. PubMed ID: 29138037
[TBL] [Abstract][Full Text] [Related]
3. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
4. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
5. Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy.
Tyrmi JS; Kaartokallio T; Lokki AI; Jääskeläinen T; Kortelainen E; Ruotsalainen S; Karjalainen J; Ripatti S; Kivioja A; Laisk T; Kettunen J; Pouta A; Kivinen K; Kajantie E; Heinonen S; Kere J; Laivuori H;
JAMA Cardiol; 2023 Jul; 8(7):674-683. PubMed ID: 37285119
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic profile and smoking in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Suomalainen-König S; Hämäläinen E; Pulkki K; Romppanen J; Heinonen S; Laivuori H;
Ann Med; 2017 Nov; 49(7):593-602. PubMed ID: 28537456
[TBL] [Abstract][Full Text] [Related]
7. Increased Risk of Preeclampsia in Women With a Genetic Predisposition to Elevated Blood Pressure.
Kivioja A; Toivonen E; Tyrmi J; Ruotsalainen S; Ripatti S; Huhtala H; Jääskeläinen T; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Saarela T; Laivuori H
Hypertension; 2022 Sep; 79(9):2008-2015. PubMed ID: 35862124
[TBL] [Abstract][Full Text] [Related]
8. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia.
McGinnis R; Steinthorsdottir V; Williams NO; Thorleifsson G; Shooter S; Hjartardottir S; Bumpstead S; Stefansdottir L; Hildyard L; Sigurdsson JK; Kemp JP; Silva GB; Thomsen LCV; Jääskeläinen T; Kajantie E; Chappell S; Kalsheker N; Moffett A; Hiby S; Lee WK; Padmanabhan S; Simpson NAB; Dolby VA; Staines-Urias E; Engel SM; Haugan A; Trogstad L; Svyatova G; Zakhidova N; Najmutdinova D; ; ; Dominiczak AF; Gjessing HK; Casas JP; Dudbridge F; Walker JJ; Pipkin FB; Thorsteinsdottir U; Geirsson RT; Lawlor DA; Iversen AC; Magnus P; Laivuori H; Stefansson K; Morgan L
Nat Genet; 2017 Aug; 49(8):1255-1260. PubMed ID: 28628106
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period.
Goel A; Maski MR; Bajracharya S; Wenger JB; Zhang D; Salahuddin S; Shahul SS; Thadhani R; Seely EW; Karumanchi SA; Rana S
Circulation; 2015 Nov; 132(18):1726-33. PubMed ID: 26416810
[TBL] [Abstract][Full Text] [Related]
10. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
[TBL] [Abstract][Full Text] [Related]
11. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
[TBL] [Abstract][Full Text] [Related]
12. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
Asvold BO; Eskild A; Vatten LJ
Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
[TBL] [Abstract][Full Text] [Related]
13. An RGS2 3'UTR polymorphism is associated with preeclampsia in overweight women.
Karppanen T; Kaartokallio T; Klemetti MM; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Staff AC; Laivuori H
BMC Genet; 2016 Aug; 17(1):121. PubMed ID: 27558088
[TBL] [Abstract][Full Text] [Related]
14. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.
Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB
Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite polymorphism in the heme oxygenase-1 promoter is associated with nonsevere and late-onset preeclampsia.
Kaartokallio T; Klemetti MM; Timonen A; Uotila J; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Lakkisto P; Laivuori H
Hypertension; 2014 Jul; 64(1):172-7. PubMed ID: 24799610
[TBL] [Abstract][Full Text] [Related]
17. Preeclampsia does not share common risk alleles in 9p21 with coronary artery disease and type 2 diabetes.
Kaartokallio T; Lokki AI; Peterson H; Kivinen K; Hiltunen L; Salmela E; Lappalainen T; Maanselkä P; Heino S; Knuutila S; Sayed A; Poston L; Brennecke SP; Johnson MP; Morgan L; Moses EK; Kere J; Laivuori H
Ann Med; 2016 Aug; 48(5):330-6. PubMed ID: 27111527
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample.
Kivinen K; Peterson H; Hiltunen L; Laivuori H; Heino S; Tiala I; Knuutila S; Rasi V; Kere J
Eur J Hum Genet; 2007 Apr; 15(4):494-7. PubMed ID: 17290274
[TBL] [Abstract][Full Text] [Related]
19. Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile.
Procopciuc LM; Caracostea G; Zaharie G; Stamatian F
J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1754-60. PubMed ID: 25007988
[TBL] [Abstract][Full Text] [Related]
20. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]